Table 3.
[en] Overall survival as a function of baseline demographic, clinical, and tumor features in all patients treated with cystectomy
| Variable | Category | No. (%) of all patients | No. (%) of patients who died during follow-up | Unadjusted hazard ratio | 95% confidence interval | p value |
|---|---|---|---|---|---|---|
| Total | 210 (100%) | 95 (45.2) | ||||
| Gender | Female | 44 (21.0) | 21 (47.7) | [em] | [em] | |
| Male | 166 (79.0) | 74 (44.6) | 0.87 | 0.54[en]1.4 2 |
0.5831 | |
| Race | White | 186 (88.6) | 79 (42.5) | [em] | [em] | |
| Black | 24 (11.4) | 16 (66.7) | 1.83 | 1.07[en]3.1 3 |
0.0281 | |
| Age | ≤65 | 93 (44.3) | 32 (34.4) | [em] | [em] | |
| 66[en]75 | 71 (33.8) | 39 (54.9) | 1.72 | 1.08[en]2.7 4 |
0.0237 | |
| ≥76 | 46 (21.9) | 24 (52.2) | 1.58 | 0.93[en]2.6 7 |
0.0928 | |
| Stage | 0 | 18 (8.6) | 5 (27.8) | [em] | [em] | |
| I | 22 (10.5) | 6 (27.3) | 0.99 | 0.30[en]3.2 5 |
0.9861 | |
| II | 61 (29.0) | 17 (27.9) | 1.14 | 0.42[en]3.0 9 |
0.7991 | |
| III | 66 (31.4) | 36 (54.5) | 2.95 | 1.15[en]7.5 2 |
0.0239 | |
| IV | 43 (20.5) | 31 (72.1) | 4.33 | 1.68[en]11. 16 |
0.0024 | |
| Comorbidity | 0 | 70 (33.3) | 28 (40.0) | [em] | [em] | |
| 1 | 72 (34.3) | 34 (47.2) | 1.40 | 0.85[en]2.3 2 |
0.1857 | |
| 2 | 46 (21.9) | 20 (43.5) | 1.15 | 0.65[en]2.0 4 |
0.6438 | |
| 3 | 22 (10.5) | 13 (59.1) | 2.33 | 1.20[en]4.5 1 |
0.0122 | |
| Grade** | Low (I, II) | 24 (11.4) | 8 (33.3) | [em] | [em] | |
| High (III, IV) |
178 (84.8) | 84 (47.2) | 1.74 | 0.93[en]3.2 6 |
0.0847 |
**
Eight patients were not assigned a grade and were censored.